Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

The prognostic impact of p53 immunostaining in a large series of tumours from epithelial ovarian cancer patients in a two-centre study was analysed. The study population (n=476) comprised of a retrospective series of 188 patients (Dutch cohort) and a prospective series of 288 patients (Scottish coho...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: de Graeff, P, Hall, J, Crijns, A P G, de Bock, G H, Paul, J, Oien, K A, ten Hoor, K A, de Jong, S, Hollema, H, Bartlett, J M S, Brown, R, van der Zee, A G J
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2006
Sujets:
Molecular Diagnostics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360689/
https://ncbi.nlm.nih.gov/pubmed/16880779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603300
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires